Clinical Trials in San Francisco

Showing 5461-5480 of 12,991 trials

Naltrexone Effects on Alcohol Intake

NCT00254670

The purpose of this study is to examine drinking behavior and decision-making while taking Naltrexone and placebo. This is a double-blind, randomized, placebo-controlled crossover study. There are two cycles: one cycle on Naltrexone and one cycle on placebo.

Social Drinker

University of California, San FranciscoStarted Feb 2005

San Francisco, California, United States

COMPLETEDPhase 2/3< 1 mile

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601

The purpose of this clinical trial is to learn whether the study medicine prevent symptoms of COVID-19 in adults who have been exposed to household member(s) with a confirmed symptomatic COVID-19 infection. All participants in the study will receive treatment for COVID-19 as needed, based on their regular doctor's recommendation. Two-thirds of participants will also receive two study medicines (PF-07321332 and ritonavir) by mouth twice a day for either five or ten days. We will compare the experiences of people receiving the study medicines to those of the people who do not. This will help us determine if the study medicines are safe and effective

COVID-19

Pfizer2,954 participantsStarted Sep 2021

Pelham, Alabama, United States • Tucson, Arizona, United States • Fullerton, California, United States +167 more locations

Naltrexone Effects on Alcohol Intake

A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

Find Trials by Condition in San Francisco

Double-Blind Randomized Controlled Trial for the Evaluation of a Novel Adaptive Attention Training in Healthy Adolescents

Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Closed-Loop Deep Brain Stimulation for Major Depression

Detection of Urinary Human Chorionic Gonadotropin (hCG)

Sleep and Cardiovascular Health in Adolescence

S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

Study Evaluating the Efficacy and Safety of Yoni.Fit in Women With Stress Urinary Incontinence

Efficacy and Safety of IDP-124 Lotion for the Treatment of Moderate to Severe Atopic Dermatitis in Pediatric and Adult Subjects

First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.

A Study of Weekly Tisotumab Vedotin for Patients With Platinum-Resistant Ovarian Cancer With Safety Run-in (innovaTV 208)

G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer

ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent

Getting to an Improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD) a Registry of High Cardiovascular Risk Subjects in the United States

Class II Correction Study Using the Invisalign System

The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial

Safety Study of SEA-CD40 in Cancer Patients

MK-7625A Plus Metronidazole Versus Meropenem in Pediatric Participants With Complicated Intra-Abdominal Infection (cIAI) (MK-7625A-035)

A Randomized, Double Blind, Placebo Controlled Study of Etanercept in Children With Kawasaki Disease